Prostatitis
Conditions
Brief summary
Evaluate the effect of TECAR therapy on pain, voiding, erectile function, sleep quality and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome.
Detailed description
Sixty men with chronic prostatitis/chronic pelvic pain will be sourced from the urology outpatient clinic at Tanta University hospitals in Egypt, with referrals from urologists. Patients will be randomly assigned into two groups. Study group: It will include 30 men receiving true TECAR therapy plus dietary and life style adjustments. Control group: It will include 30 men receiving sham TECAR therapy plus dietary and life style adjustments. Evaluation Procedures: 1. Pain, voiding, and quality of life using the National Institutes of Health-Chronic Prostatitis Symptom Index. 2. Sleep quality using the Pittsburgh Sleep Quality Index. 3. Erectile function using the International Index of Erectile Function.
Interventions
DEVICESham TECAR therapy
The procedure is similar to the active treatment of TECAR, but with the critical difference being that the output intensity of the TECAR device will be set to zero during the session.
DEVICETECAR therapy
WINBACK 3SE (France) will be used for TECAR therapy in this study. To facilitate optimal distribution of endogenous heat therapy and effective contact between the active electrodes, both capacitive and resistive, and the surface of the skin, a layer of high-conductivity cream will be applied to the treatment region. The plate, an inactive electrode, which has a specific size (21cm\*15cm), will be placed on the gluteal region. The capacitive electrode was employed for a duration of seven and a half minutes, at an intensity of 30-40%, whereas the resistance electrode will be utilized for an equivalent period over the perineum at the same intensity.
Sponsors
Middle East University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
MALE
Age
30 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* Presence of chronic prostatitis/chronic pelvic pain symptoms for more than 6 months. * Ages will be ranged from 30 to 50 years old.
Exclusion criteria
1. Urinary and seminal infections. 2. Recent parenteral steroid administration. 3. Prior prostate or pelvic surgery. 4. Lower urinary tract disorders such as bladder stones. 5. Implanted electronic devices as pacemakers. 6. Sensory loss over the perineum.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pelvic pain | Baseline and 8 weeks later | Pain will be assessed using the National Institutes of Health-Chronic Prostatitis Symptom Index |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of life of men | Baseline and after 8 weeks | Quality of life will be assessed using the National Institutes of Health-Chronic Prostatitis Symptom Index |
Countries
Egypt
Contacts
Primary ContactSaher Elgayar, Ph.D
Backup ContactMohammed Elhamrawy, Ph.D
Outcome results
None listed